eo against candida spp yeasts reference Search Results


b orellana eo against candida albicans  (ATCC)
99
ATCC b orellana eo against candida albicans
B. <t>orellana</t> leaves.
B Orellana Eo Against Candida Albicans, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/b orellana eo against candida albicans/product/ATCC
Average 99 stars, based on 1 article reviews
b orellana eo against candida albicans - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
pelargonium graveolens eo against candida tropicalis atcc 750  (ATCC)
97
ATCC pelargonium graveolens eo against candida tropicalis atcc 750
B. <t>orellana</t> leaves.
Pelargonium Graveolens Eo Against Candida Tropicalis Atcc 750, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pelargonium graveolens eo against candida tropicalis atcc 750/product/ATCC
Average 97 stars, based on 1 article reviews
pelargonium graveolens eo against candida tropicalis atcc 750 - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier
90029 strain biofilms  (ATCC)
96
ATCC 90029 strain biofilms
Origanum vulgare essential oil inhibits biofilm formation. Biofilm scratch assay. 24 h formed <t>biofilms</t> were scratched (T0) and then incubated for additional 24 h in absence (control, DMSO) or presence of treatments at different concentrations (MIC, 1/2 MIC, 2xMIC). After this period, scratched area was quantified and compared with T0. Bars represent the quantification of the healing of the wound area (mean + SD, n = 3), expressed as the percentage relative to T0. *p < 0.1, **p < 0.01, ***p < 0.001, ****p < 0.0001 with respect to control (vehicle, DMSO); ††p < 0.01, †††p < 0.001 with respect to the indicated bar (two-way ANOVA). O-EO: Origanum essential oil
90029 Strain Biofilms, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/90029 strain biofilms/product/ATCC
Average 96 stars, based on 1 article reviews
90029 strain biofilms - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
eo against candida spp yeasts reference  (ATCC)
99
ATCC eo against candida spp yeasts reference
Origanum vulgare essential oil inhibits biofilm formation. Biofilm scratch assay. 24 h formed <t>biofilms</t> were scratched (T0) and then incubated for additional 24 h in absence (control, DMSO) or presence of treatments at different concentrations (MIC, 1/2 MIC, 2xMIC). After this period, scratched area was quantified and compared with T0. Bars represent the quantification of the healing of the wound area (mean + SD, n = 3), expressed as the percentage relative to T0. *p < 0.1, **p < 0.01, ***p < 0.001, ****p < 0.0001 with respect to control (vehicle, DMSO); ††p < 0.01, †††p < 0.001 with respect to the indicated bar (two-way ANOVA). O-EO: Origanum essential oil
Eo Against Candida Spp Yeasts Reference, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/eo against candida spp yeasts reference/product/ATCC
Average 99 stars, based on 1 article reviews
eo against candida spp yeasts reference - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
eo against candida albicans  (ATCC)
95
ATCC eo against candida albicans
Origanum vulgare essential oil inhibits biofilm formation. Biofilm scratch assay. 24 h formed <t>biofilms</t> were scratched (T0) and then incubated for additional 24 h in absence (control, DMSO) or presence of treatments at different concentrations (MIC, 1/2 MIC, 2xMIC). After this period, scratched area was quantified and compared with T0. Bars represent the quantification of the healing of the wound area (mean + SD, n = 3), expressed as the percentage relative to T0. *p < 0.1, **p < 0.01, ***p < 0.001, ****p < 0.0001 with respect to control (vehicle, DMSO); ††p < 0.01, †††p < 0.001 with respect to the indicated bar (two-way ANOVA). O-EO: Origanum essential oil
Eo Against Candida Albicans, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/eo against candida albicans/product/ATCC
Average 95 stars, based on 1 article reviews
eo against candida albicans - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
candida sp  (ATCC)
93
ATCC candida sp
Origanum vulgare essential oil inhibits biofilm formation. Biofilm scratch assay. 24 h formed <t>biofilms</t> were scratched (T0) and then incubated for additional 24 h in absence (control, DMSO) or presence of treatments at different concentrations (MIC, 1/2 MIC, 2xMIC). After this period, scratched area was quantified and compared with T0. Bars represent the quantification of the healing of the wound area (mean + SD, n = 3), expressed as the percentage relative to T0. *p < 0.1, **p < 0.01, ***p < 0.001, ****p < 0.0001 with respect to control (vehicle, DMSO); ††p < 0.01, †††p < 0.001 with respect to the indicated bar (two-way ANOVA). O-EO: Origanum essential oil
Candida Sp, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/candida sp/product/ATCC
Average 93 stars, based on 1 article reviews
candida sp - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

Image Search Results


B. orellana leaves.

Journal: Life

Article Title: In Vitro Evaluation of the Antifungal Properties of Bixa orellana L. Essential Oil from the Ecuadorian Amazon Against Candida albicans (ATCC 10231)

doi: 10.3390/life14121628

Figure Lengend Snippet: B. orellana leaves.

Article Snippet: The antifungal activity of B. orellana EO against Candida albicans (ATCC 10231) was evaluated using the Kirby–Bauer method [ ].

Techniques:

Chromatogram of the EO of B. orellana .

Journal: Life

Article Title: In Vitro Evaluation of the Antifungal Properties of Bixa orellana L. Essential Oil from the Ecuadorian Amazon Against Candida albicans (ATCC 10231)

doi: 10.3390/life14121628

Figure Lengend Snippet: Chromatogram of the EO of B. orellana .

Article Snippet: The antifungal activity of B. orellana EO against Candida albicans (ATCC 10231) was evaluated using the Kirby–Bauer method [ ].

Techniques:

Chemical composition of the EO of B. orellana leaves.

Journal: Life

Article Title: In Vitro Evaluation of the Antifungal Properties of Bixa orellana L. Essential Oil from the Ecuadorian Amazon Against Candida albicans (ATCC 10231)

doi: 10.3390/life14121628

Figure Lengend Snippet: Chemical composition of the EO of B. orellana leaves.

Article Snippet: The antifungal activity of B. orellana EO against Candida albicans (ATCC 10231) was evaluated using the Kirby–Bauer method [ ].

Techniques: Molecular Weight

Antifungal activity of B. orellana EO: inhibition halos ( a ) and statistical comparison with nystatin ( b ).

Journal: Life

Article Title: In Vitro Evaluation of the Antifungal Properties of Bixa orellana L. Essential Oil from the Ecuadorian Amazon Against Candida albicans (ATCC 10231)

doi: 10.3390/life14121628

Figure Lengend Snippet: Antifungal activity of B. orellana EO: inhibition halos ( a ) and statistical comparison with nystatin ( b ).

Article Snippet: The antifungal activity of B. orellana EO against Candida albicans (ATCC 10231) was evaluated using the Kirby–Bauer method [ ].

Techniques: Activity Assay, Inhibition, Comparison

Origanum vulgare essential oil inhibits biofilm formation. Biofilm scratch assay. 24 h formed biofilms were scratched (T0) and then incubated for additional 24 h in absence (control, DMSO) or presence of treatments at different concentrations (MIC, 1/2 MIC, 2xMIC). After this period, scratched area was quantified and compared with T0. Bars represent the quantification of the healing of the wound area (mean + SD, n = 3), expressed as the percentage relative to T0. *p < 0.1, **p < 0.01, ***p < 0.001, ****p < 0.0001 with respect to control (vehicle, DMSO); ††p < 0.01, †††p < 0.001 with respect to the indicated bar (two-way ANOVA). O-EO: Origanum essential oil

Journal: BMC Complementary Medicine and Therapies

Article Title: Origanum vulgare L. essential oil inhibits virulence patterns of Candida spp. and potentiates the effects of fluconazole and nystatin in vitro

doi: 10.1186/s12906-022-03518-z

Figure Lengend Snippet: Origanum vulgare essential oil inhibits biofilm formation. Biofilm scratch assay. 24 h formed biofilms were scratched (T0) and then incubated for additional 24 h in absence (control, DMSO) or presence of treatments at different concentrations (MIC, 1/2 MIC, 2xMIC). After this period, scratched area was quantified and compared with T0. Bars represent the quantification of the healing of the wound area (mean + SD, n = 3), expressed as the percentage relative to T0. *p < 0.1, **p < 0.01, ***p < 0.001, ****p < 0.0001 with respect to control (vehicle, DMSO); ††p < 0.01, †††p < 0.001 with respect to the indicated bar (two-way ANOVA). O-EO: Origanum essential oil

Article Snippet: The effect of O-EO was similar to that of nystatin against the ATCC 90029 strain biofilms ( p > 0.05), but the IC 50 value was significantly lower than that of nystatin for ATCC 10231 (2.8 mg/L O-EO vs. 15.2 mg/L nystatin, p < 0.0001).

Techniques: Wound Healing Assay, Incubation

Effect of Origanum vulgare essential oil combined with fluconazole and nystatin on the viability of biofilms. The effects of the combination of O-EO with fluconazole (upper row) and nystatin (lower row) on cell viability were measured using the MTT reduction assay in two C. albicans strains : ATCC 90029 (left panels) and ATCC 10231 (right panels). Preformed biofilms (24 h) were exposed to the different drugs for 24 h. Seven concentrations were mixed in every possible combination to obtain an effect matrix plotted with the Combenefit software. The graphs at the left of each panel represent a XYZ model of the combination and is analyzed according to Loewe’s model of drug additivity. At the right of each graph is the matrix of combinations that shows the differences between the theoretical combinations and empirical data by a number generated for each point. Positive numbers are given for synergistic combinations, whereas negative numbers indicate antagonism. Color code indicates statistical significance of the difference between theorical and empirical model (Student’s t-test). * p < 0.05. The graphs show the mean ± standard deviation of three independent experiments

Journal: BMC Complementary Medicine and Therapies

Article Title: Origanum vulgare L. essential oil inhibits virulence patterns of Candida spp. and potentiates the effects of fluconazole and nystatin in vitro

doi: 10.1186/s12906-022-03518-z

Figure Lengend Snippet: Effect of Origanum vulgare essential oil combined with fluconazole and nystatin on the viability of biofilms. The effects of the combination of O-EO with fluconazole (upper row) and nystatin (lower row) on cell viability were measured using the MTT reduction assay in two C. albicans strains : ATCC 90029 (left panels) and ATCC 10231 (right panels). Preformed biofilms (24 h) were exposed to the different drugs for 24 h. Seven concentrations were mixed in every possible combination to obtain an effect matrix plotted with the Combenefit software. The graphs at the left of each panel represent a XYZ model of the combination and is analyzed according to Loewe’s model of drug additivity. At the right of each graph is the matrix of combinations that shows the differences between the theoretical combinations and empirical data by a number generated for each point. Positive numbers are given for synergistic combinations, whereas negative numbers indicate antagonism. Color code indicates statistical significance of the difference between theorical and empirical model (Student’s t-test). * p < 0.05. The graphs show the mean ± standard deviation of three independent experiments

Article Snippet: The effect of O-EO was similar to that of nystatin against the ATCC 90029 strain biofilms ( p > 0.05), but the IC 50 value was significantly lower than that of nystatin for ATCC 10231 (2.8 mg/L O-EO vs. 15.2 mg/L nystatin, p < 0.0001).

Techniques: MTT Reduction Assay, Software, Generated, Standard Deviation